Digital therapeutics, medication adherence, clinical trials were key pharma interests in Q2

Pharma companies are getting more and more open about their digital health initiatives, which has given MobiHealthNews more opportunities this quarter than usual to chronicle pharma ’s efforts around adherence, clinical trials, and the burgeoning world of digital therapeutics. In addition, at the BIO conference in Boston this quarter MobiHealthNews heard pharma innovation leaders share their stories.
Source: mobihealthnews - Category: Information Technology Source Type: news